PCRX
Pacira BioScienc (PCRX)
NASDAQ
$22.31+$0.05 (+0.25%)
Price as of Jun 03, 2026 5:18 PM EDT
  • $913.7M
    Market Cap
  • -15.72%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 34
Valuation
PCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 22
Valuation
PCRX
vs History
vs S&P 500
3-Month Momentum
11.55%
12-Month Momentum
-6.86%
3-Month Risk Adjusted Momentum
77.55%
12-Month Risk Adjusted Momentum
-19.24%

True Yield

N/A
Valuation
PCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
5.47%
Net Debt Paydown Yield
-7.67%

Financial Health Score

Score: 71
Valuation
PCRX
vs History
vs S&P 500
Ohlson's O-Score
7